SCHEMBL9308006

SCHEMBL9308006

O=C(O)CC(CCl)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 5/20 0.54
TDP1 Q9NUW8 2/20 0.46
CPA1 P15085 2/20 0.45
CPB1 P15086 1/20 0.45
CPA3 P15088 1/20 0.45
CPB2 Q96IY4 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
SLC22A6 Q4U2R8 1/20 0.41
TSHR P16473 1/20 0.40
GRM3 Q14832 2/20 0.37
CHRM1 P11229 1/20 0.36
AKR1A1 P14550 1/20 0.36
CHRM3 P20309 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
ADRA1A P35348 1/20 0.36
HRH1 P35367 1/20 0.36
DRD3 P35462 1/20 0.36
SLC6A3 Q01959 1/20 0.36
HDAC1 Q13547 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8160418 0.97 FOLH1 (0.52) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL34866 0.82 FOLH1 (0.65) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL1821947 0.82 FOLH1 (0.65) FOLH1TDP1CPA1CPB1CPA3
SCHEMBL6721744 0.82
Tricarballylic Acid SCHEMBL11728494 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3
SCHEMBL14591440 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL10710191 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL2462503 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL8329654 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3
Tricarballylic Acid SCHEMBL11736211 0.79 FOLH1 (0.62) FOLH1TDP1CPA1CPB1CPA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104245659-B The method being produced acid anhydrides by epoxides 诺沃梅尔公司 2016-08-24 CN disclosed
US-9403788-B2 Process for the production of acid anhydrides from epoxides NOVOMER, INC. (US) 2016-08-02 US disclosed
US-20150005513-A1 PROCESS FOR THE PRODUCTION OF ACID ANHYDRIDES FROM EPOXIDES NOVOMER, INC. 2015-01-01 US disclosed
EP-2814805-A1 PROCESS FOR THE PRODUCTION OF ACID ANHYDRIDES FROM EPOXIDES Novomer, Inc. (US) 2014-12-24 EP disclosed
WO-2013122905-A1 PROCESS FOR THE PRODUCTION OF ACID ANHYDRIDES FROM EPOXIDES NOVOMER, INC. (US) 2013-08-22 WO disclosed
US-5347008-A Thio(cyclo) alkanepolycarboxylic acids containing heterocyclic substituents CIBA-GEIGY CORPORATION (US) 1994-09-13 US disclosed
US-5152929-A Corrosion inhibitors for water systems CIBA-GEIGY CORPORATION (US) 1992-10-06 US disclosed
US-5068119-A Dietetics with fat substitutes NABISCO BRANDS, INC. (US) 1991-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150005513-A1 PROCESS FOR THE PRODUCTION OF ACID ANHYDRIDES FROM EPOXIDES CA4, CA1, CA12 FOLH1 232/4885TDP1 4737/4885CPA1 813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.